Precision Medicine and Pharmacogenomics in Clinical Oncology

The International Journal of Clinical Pharmacy and Medicine (IJCPM) invites submissions focused on Precision Medicine and Pharmacogenomics in Clinical Oncology.

We welcome original research, reviews, clinical studies, implementation reports, and case series examining how genomic, molecular, and patient-specific factors can guide cancer therapy and improve treatment outcomes.

Topics of interest include pharmacogenomic-guided drug selection and dosing, targeted therapies, biomarker-driven treatment, oncology pharmacokinetics and pharmacodynamics, toxicity prediction, therapeutic drug monitoring, precision supportive care, drug–gene interactions, and integration of genomic data into clinical decision-making.

Submissions addressing the practical implementation, clinical utility, cost-effectiveness, ethical considerations, and multidisciplinary application of precision oncology are particularly encouraged.

IJCPM welcomes contributions from oncologists, clinical pharmacists, pharmacologists, geneticists, researchers, and multidisciplinary cancer care teams worldwide.